Skip to main content
SpringerLink
Log in

The spectrum of neuroendocrine differentiation in prostate cancer

  • Correspondence
  • Published:
Prostate Cancer and Prostatic Diseases Submit manuscript

The Original Article was published on 20 April 2020

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: NE features of PCa cell lines.

References

  1. Cheng S, Prieto-Dominguez N, Yang S, Connelly ZM, StPierre S, Rushing B, et al. The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer. Prostate Cancer Prostatic Dis. 2020;23:661–9.

  2. Bang YJ, Pirnia F, Fang WG, Kang WK, Sartor O, Whitesell L, et al. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci. 1994;91:5330–4.

    Article  CAS  Google Scholar 

  3. Yadav SS, Li J, Stockert JA, Herzog B, O’Connor J, Garzon-Manco L, et al. Induction of neuroendocrine differentiation in prostate cancer cells by dovitinib (TKI-258) and its therapeutic implications. Transl Oncol. 2017;10:357–66.

    Article  Google Scholar 

  4. Jung Y, Cackowski FC, Yumoto K, Decker AM, Wang J, Kim JK, et al. CXCL12γ promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypes. Cancer Res. 2018;78:2026–39.

    Article  CAS  Google Scholar 

  5. Lee E, Wang J, Jung Y, Cackowski FC, Taichman RS. Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancer. J Cell Biochem. 2018;119:3697–705.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research is supported by NIH R01 CA226285 grant to YX.

Author information

Authors and Affiliations

  1. Department of Biochemistry & Molecular Biology, LSU Health Shreveport, Shreveport, LA, USA

    Siyuan Cheng & Xiuping Yu

Authors
  1. Siyuan Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiuping Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiuping Yu.

Ethics declarations

Conflict of interest

The authors declare no competing interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, S., Yu, X. The spectrum of neuroendocrine differentiation in prostate cancer. Prostate Cancer Prostatic Dis 24, 1214–1215 (2021). https://doi.org/10.1038/s41391-021-00386-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-021-00386-5

  • Springer Nature Limited

Search

Navigation